close 73% de los inversores minoristas pierde dinero cuando opera CFDs con este proveedor. Invertir conlleva riesgos y no es adecuado para todos los inversores. Los CFDs son instrumentos complejos y conllevan un alto riesgo de perder dinero rápidamente debido al apalancamiento. 73% de inversores minoristas pierde dinero al operar CFDs con este proveedor. Debes considerar si entiendes cómo funcionan los CFDs y si puedes permitirte asumir el alto riesgo de perder tu dinero.
BuscarBuscar
Change languageEspañol
Dashboard

LLY

1,037

+2.17%↑

JNJ

244.47

+1.48%↑

ABBV

227.53

+3.09%↑

NVS

160.86

+0.83%↑

MRK

119.17

-0.13%↓

LLY

1,037

+2.17%↑

JNJ

244.47

+1.48%↑

ABBV

227.53

+3.09%↑

NVS

160.86

+0.83%↑

MRK

119.17

-0.13%↓

LLY

1,037

+2.17%↑

JNJ

244.47

+1.48%↑

ABBV

227.53

+3.09%↑

NVS

160.86

+0.83%↑

MRK

119.17

-0.13%↓

LLY

1,037

+2.17%↑

JNJ

244.47

+1.48%↑

ABBV

227.53

+3.09%↑

NVS

160.86

+0.83%↑

MRK

119.17

-0.13%↓

LLY

1,037

+2.17%↑

JNJ

244.47

+1.48%↑

ABBV

227.53

+3.09%↑

NVS

160.86

+0.83%↑

MRK

119.17

-0.13%↓

Inicio・Lista de Acciones・VIRIDIAN THERAPEUTICS INC
Search

VIRIDIAN THERAPEUTICS INC

Cerrado

SectorSanidad

28.72 -4.04

Compra Fuerte

Precios actualizados 12 feb 2026, 20:59 UTC

ComprarVender

Resumen

Variación precio

24h

Actual

Mínimo

28.43

Máximo

30.05

Métricas clave

By Trading Economics

Ingresos

66M

-35M

Ventas

70M

71M

Margen de beneficios

-49.028

Empleados

143

EBITDA

66M

-34M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+41.42% upside

Dividendos

By Dow Jones

Próximas Ganancias

25 feb 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

670M

2.8B

Apertura anterior

32.76

Cierre anterior

28.72

Noticias sobre sentimiento de mercado

By Acuity

33%

67%

89 / 352 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

12 / 13.14 Soporte y Resistencia

VIRIDIAN THERAPEUTICS INC Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

12 feb 2026, 23:57 UTC

Acciones populares

Stocks to Watch: Applied Materials, Arista, DraftKings, Pinterest

DJ

Leer

12 feb 2026, 23:35 UTC

Ganancias
Principales Movimientos del Mercado

Arista Networks Surges on AI Networking Demand, Despite Rising Costs

DJ

Leer

12 feb 2026, 23:28 UTC

Ganancias

Applied Materials Profit Rises on Soaring AI Demand -- Update

DJ

Leer

12 feb 2026, 21:47 UTC

Ganancias

Vertex Pharmaceuticals Revenue Climbs on Continued Cystic Fibrosis Demand

DJ

Leer

13 feb 2026, 00:00 UTC

Charlas de Mercado

ANZ Gets a New Bull as Productivity Prospects Improve -- Market Talk

DJ

Leer

12 feb 2026, 23:47 UTC

Charlas de Mercado

Nikkei May Fall After AI Concerns Drag Stocks on Wall Street -- Market Talk

DJ

Leer

12 feb 2026, 23:38 UTC

Charlas de Mercado

Gold Steady; Could Undergo Technical Recovery -- Market Talk

DJ

Leer

12 feb 2026, 23:33 UTC

Ganancias

Coinbase Swings to a Fourth-Quarter Loss Amid Crypto Meltdown -- 2nd Update

DJ

Leer

12 feb 2026, 23:09 UTC

Charlas de Mercado

South32's Hermosa Review Stokes Spending Fears -- Market Talk

DJ

Leer

12 feb 2026, 22:55 UTC

Ganancias
Acciones populares

Applied Materials, DraftKings, Airbnb: Earnings in Focus -- WSJ

DJ

Leer

12 feb 2026, 22:46 UTC

Charlas de Mercado

Northern Star Outlook Needs Project Done On Time, In Budget -- Market Talk

DJ

Leer

12 feb 2026, 22:23 UTC

Ganancias

Coinbase Swings to a Fourth-Quarter Loss Amid Crypto Meltdown -- Update

DJ

Leer

12 feb 2026, 22:15 UTC

Ganancias

Agnico-Eagle Mines: Gold Production for 2026 and 2027, Expected at 3.3M to 3.5M Ounces Annually, Is Consistent With Previous Guidance, With Offsetting Adjustments Between Mine Sites >AEM.T

DJ

Leer

12 feb 2026, 22:15 UTC

Ganancias

Agnico-Eagle Mines Raises Dividend to 45c >AEM.T

DJ

Leer

12 feb 2026, 22:15 UTC

Ganancias

Agnico-Eagle Mines 4Q Rev $3.56B >AEM.T

DJ

Leer

12 feb 2026, 22:15 UTC

Ganancias

Agnico-Eagle Mines 4Q EPS $3.04 >AEM.T

DJ

Leer

12 feb 2026, 22:00 UTC

Ganancias

AGNICO EAGLE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - RECORD QUARTERLY AND ANNUAL FREE CASH FLOW; 2025 PRODUCTION GUIDANCE ACHIEVED; TOTAL 2025 SHAREHOLDER RETURNS OF $1.4 BILLION; DIVIDEND INCREASED BY 12.5%; UPDATED THREE-YEAR GUIDANCE >AEM.T

DJ

Leer

12 feb 2026, 22:00 UTC

Ganancias

Agnico-Eagle Mines 4Q Rev $3.56B >AEM

DJ

Leer

12 feb 2026, 22:00 UTC

Ganancias

Agnico-Eagle Mines 4Q Net $1.52B >AEM

DJ

Leer

12 feb 2026, 22:00 UTC

Ganancias

Agnico-Eagle Mines 4Q Adj EPS $2.70 >AEM

DJ

Leer

12 feb 2026, 22:00 UTC

Ganancias

AGNICO EAGLE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - RECORD QUARTERLY AND ANNUAL FREE CASH FLOW; 2025 PRODUCTION GUIDANCE ACHIEVED; TOTAL 2025 SHAREHOLDER RETURNS OF $1.4 BILLION; DIVIDEND INCREASED BY 12.5%; UPDATED THREE-YEAR GUIDANCE >AEM.T

DJ

Leer

12 feb 2026, 22:00 UTC

Ganancias

Agnico-Eagle Mines 4Q EPS $3.04 >AEM

DJ

Leer

12 feb 2026, 21:57 UTC

Ganancias

XP 4Q Rev BRL4.95B >XP

DJ

Leer

12 feb 2026, 21:52 UTC

Ganancias

Coinbase Revenue Falls Short as Crypto Market Sags -- Barrons.com

DJ

Leer

12 feb 2026, 21:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

DJ

Leer

12 feb 2026, 21:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

DJ

Leer

12 feb 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

DJ

Leer

12 feb 2026, 21:47 UTC

Ganancias

Morningstar 4Q Rev $641M >MORN

DJ

Leer

12 feb 2026, 21:39 UTC

Ganancias

Coinbase Revenue Falls Short as Crypto Market Sags -- Barrons.com

DJ

Leer

12 feb 2026, 21:38 UTC

Ganancias

Howmet Stock Jumps. Earnings Show Strength For This Sector. -- Barrons.com

DJ

Leer

Comparación entre iguales

Cambio de precio

VIRIDIAN THERAPEUTICS INC previsión

Precio Objetivo

By TipRanks

41.42% repunte

Estimación a 12 Meses

Media 41.86 USD  41.42%

Máximo 50 USD

Mínimo 29 USD

De acuerdo con 10 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para VIRIDIAN THERAPEUTICS INC Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

10 ratings

9

Comprar

1

Mantener

0

Vender

De acuerdo con 10 analistas que ofrecen calificaciones bursátiles a para VIRIDIAN THERAPEUTICS INC Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

12 / 13.14Soporte y Resistencia

Corto Plazo

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Medio plazo

Bearish Evidence

All events are bearish.

Largo Plazo

Strong Bearish Evidence

All events are bearish.

Sentimiento

By Acuity

89 / 352 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Otras acciones del sector

LLY

Eli Lilly and Co.

1,037

↑ +2.17%

JNJ

Johnson and Johnson

244.47

↑ +1.48%

ABBV

AbbVie Inc

227.53

↑ +3.09%

NVS

Novartis AG

160.86

↑ +0.83%

MRK

Merck & Co Inc.

119.17

↓-0.13%
help-icon Live chat